MsFLASH clinical trials network findings remain key guide for menopause care

The MsFLASH clinical trials network generated pooled evidence on treating menopause symptoms that remains a practical anchor for healthcare providers, Contemporary OB/GYN reported. Susan Reed, a professor emeritus of obstetrics and gynecology at the University of Washington in Seattle, presented the findings at The Menopause Society Annual Meeting. [1]

According to Contemporary OB/GYN, Reed described MsFLASH as one of three major menopause research initiatives, alongside the SWAN study and the Women’s Health Initiative. Reed noted that MsFLASH was the first, and currently the last, clinical trials network funded by the National Institutes of Health in this research area. [1]

The network evaluated multiple approaches to managing menopausal health. Contemporary OB/GYN reported that the trial findings demonstrated nonhormonal therapies with efficacy comparable to low-dose estradiol, alongside cognitive behavioral therapy options for sleep management. [1]

Hormone replacement therapy is commonly used to treat symptoms caused by declining female sex hormone levels during menopause. These symptoms can include hot flashes, vaginal dryness, accelerated skin aging, decreased muscle mass, sexual dysfunction, and complications such as osteoporosis. [2]